Market Overview:
The global pefloxacin mesylate market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of infectious diseases, increasing demand for pefloxacin mesylate from hospital pharmacies and retail pharmacies, and growing awareness about the benefits of pefloxacin mesylate. However, stringent regulatory requirements for drug approvals are likely to restrain the growth of this market during the forecast period. Based on type, the global pefloxacin mesylate market is segmented into tablet, capsule and injection. The tablet segment is expected to account for a major share of the global market in 2018 owing to its high usage rates across all applications segments. By application, hospital pharmacy accounted for a major share of the global market in 2017 due to rising demand for antibiotics from hospitals across regions.
Product Definition:
Pefloxacin Mesylate is a quinolone antibiotic used to treat bacterial infections. It inhibits DNA replication, transcription, and translation, and is also a potent inhibitor of bacterial topoisomerases.
Tablet:
Tablet is a form of oral drug delivery system that consists of an inert core containing the active pharmaceutical ingredient (API) and a coating around it, which dissolves in the mouth. The drug is released gradually over an appropriate period as per requirement. Tablets are easy to swallow and offer controlled release of drugs, thus making them ideal for patients who take multiple medications or for chronic conditions like arthritis where regular dose administration is painful or difficult.
Capsule:
Capsule is a small package containing drug substance and the coating which protects it from getting damaged during delivery. The drug substances can be in the form of tablets, capsules or even in liquid form. The size of capsule depends on the dosage that needs to be administered. Capsules are used for oral medications and they help protect drugs against stomach acids so that they can remain effective until it is reached inside the body.
Application Insights:
The others segment that includes home healthcare, veterinary and other applications accounted for the largest share of the global market in 2017. The product is widely used for treating skin infections such as abrasions, burns, scratches and insect bites. It is also employed to treat various animal diseases including diarrhea caused by Vibrio parahaemolyticus; respiratory tract infections such as bronchitis caused by Streptococcus pneumoniae; urinary tract infections due to Escherichia coli; gastrointestinal parasites like hookworms and whipworms among others.
Pefloxacin mesylate injection is a popular drug in veterinary medicine owing to its ability to treat a wide range of bacterial diseases with few injections. In addition, it can be used for preventing disease outbreaks caused due largely or entirelyto bacteria including salmonella infection (food poisoning), staphylococcal infection (skin infections) among others at pet stores or farms where animals are kept together with humans on a daily basis e.
Regional Analysis:
Asia Pacific was the largest market in 2016 and is expected to continue its dominance over the forecast period. The presence of a large number of local manufacturers coupled with increasing demand for generic drugs is anticipated to drive the regional market. In addition, growing healthcare expenditure and rising awareness about antibiotic resistance are expected to further propel growth during the forecast period.
The product launch by companies such as WOCKHARDT GMBH & CO., KG; GlaxoSmithKline plc.; Novartis AG; Sandoz International Gmbh; Allergan PLC; Pfizer Inc.; Bayer AG, etc. has increased availability of pefloxacin mesylate in Europe region which had led to an increase in consumption over past few years.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the pefloxacin mesylate market. This is because pefloxacin mesylate is an effective antibiotic against a wide range of bacterial infections.
- Rising demand for generic drugs: The rising demand for generic drugs across the globe is another major growth driver for the pefloxacin mesylate market. This is because generic drugs are cheaper than branded drugs and are equally effective in treating various medical conditions.
- Growing awareness about antibiotics: There has been a growing awareness about antibiotics in recent years, which has led to an increase in their use worldwide. This, in turn, is driving the growth of the pefloxacin mesylate market globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pefloxacin Mesylate Market Research Report
By Type
Tablet, Capsule, Injection
By Application
Hospital Pharmacy, Retail Pharmacy, Others
By Companies
AdvaCare Pharma, China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., Ruiyang Pharmaceutical Co., Ltd., Yichang Renfu Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Group Saite Co., Ltd., CommScope Pharmaceutical Co., Ltd., Beijing Shuanglu Pharmaceutical Co., Ltd., Beijing Sihuan Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Pefloxacin Mesylate Market Report Segments:
The global Pefloxacin Mesylate market is segmented on the basis of:
Types
Tablet, Capsule, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AdvaCare Pharma
- China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
- Ruiyang Pharmaceutical Co., Ltd.
- Yichang Renfu Pharmaceutical Co., Ltd.
- Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
- CommScope Pharmaceutical Co., Ltd.
- Beijing Shuanglu Pharmaceutical Co., Ltd.
- Beijing Sihuan Pharmaceutical Co., Ltd.
Highlights of The Pefloxacin Mesylate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- Injection
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pefloxacin Mesylate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pefloxacin mesylate is a medication used to treat bacterial infections. It is a fluoroquinolone antibiotic. Pefloxacin mesylate works by killing the bacteria that is causing the infection.
Some of the key players operating in the pefloxacin mesylate market are AdvaCare Pharma, China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., Ruiyang Pharmaceutical Co., Ltd., Yichang Renfu Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Group Saite Co., Ltd., CommScope Pharmaceutical Co., Ltd., Beijing Shuanglu Pharmaceutical Co., Ltd., Beijing Sihuan Pharmaceutical Co., Ltd..
The pefloxacin mesylate market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pefloxacin Mesylate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pefloxacin Mesylate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pefloxacin Mesylate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pefloxacin Mesylate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pefloxacin Mesylate Market Size & Forecast, 2020-2028
4.5.1 Pefloxacin Mesylate Market Size and Y-o-Y Growth
4.5.2 Pefloxacin Mesylate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Capsule
5.2.3 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pefloxacin Mesylate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pefloxacin Mesylate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Capsule
9.6.3 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Capsule
10.6.3 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Capsule
11.6.3 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Capsule
12.6.3 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Capsule
13.6.3 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pefloxacin Mesylate Market: Competitive Dashboard
14.2 Global Pefloxacin Mesylate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AdvaCare Pharma
14.3.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
14.3.3 Ruiyang Pharmaceutical Co., Ltd.
14.3.4 Yichang Renfu Pharmaceutical Co., Ltd.
14.3.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
14.3.6 CommScope Pharmaceutical Co., Ltd.
14.3.7 Beijing Shuanglu Pharmaceutical Co., Ltd.
14.3.8 Beijing Sihuan Pharmaceutical Co., Ltd.
